IL33 and breast cancer: The presence of mast cell is associated with improved prognosis in colorectal and breast cancers (68, 69); however, mast cells have also been linked to tumor promotion via induction of resistance to anti-PD-1 therapy in melanoma and IL-33-elicited macrophage mobilization in murine models of gastric cancer (70, 71).